ID   A20
AC   CVCL_1940
SY   A-20
DR   BTO; BTO:0001930
DR   CLO; CLO_0001564
DR   CLO; CLO_0050194
DR   EFO; EFO_0005285
DR   ATCC; TIB-208
DR   BCRC; 60556
DR   BCRJ; 0030
DR   BioSample; SAMN11397658
DR   ChEMBL-Cells; CHEMBL3307765
DR   ChEMBL-Targets; CHEMBL613850
DR   ENCODE; ENCBS119ENC
DR   ENCODE; ENCBS431JNZ
DR   GEO; GSM1014167
DR   Lonza; 743
DR   PubChem_Cell_line; CVCL_1940
DR   RCB; RCB2745
DR   TKG; TKG 0571
DR   TOKU-E; 459
DR   Ubigene; YC-C061
DR   Wikidata; Q54606424
RX   PubMed=310843;
RX   PubMed=22400032;
RX   PubMed=28902524;
RX   PubMed=31220119;
WW   https://en.wikipedia.org/wiki/A20_cells
WW   https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-448.html
WW   http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/A20_Stam_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 18 hours (PubMed=310843).
CC   Omics: Array-based CGH.
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/cAnN.
ST   Source(s): PubMed=31220119; Ubigene
ST   Mouse STR 1-1: 15,16
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 15,16,18
ST   Mouse STR 19-2: 14
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14,15
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 11,12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 12,13
ST   Mouse STR X-1: 25
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 24
//
RX   PubMed=310843; DOI=10.4049/jimmunol.122.2.549;
RA   Kim K.J., Kanellopoulos-Langevin C., Merwin R.M., Sachs D.H.,
RA   Asofsky R.;
RT   "Establishment and characterization of BALB/c lymphoma lines with B
RT   cell properties.";
RL   J. Immunol. 122:549-554(1979).
//
RX   PubMed=22400032; DOI=10.1155/2012/701704;
RA   Donnou S., Galand C., Touitou V., Sautes-Fridman C., Fabry Z.,
RA   Fisson S.;
RT   "Murine models of B-cell lymphomas: promising tools for designing
RT   cancer therapies.";
RL   Adv. Hematol. 2012:701704.1-701704.13(2012).
//
RX   PubMed=28902524; DOI=10.1369/0022155417731319;
RA   Guja K., Liehr T., Rincic M., Kosyakova N., Hussein Azawi S.S.;
RT   "Molecular cytogenetic characterization identified the murine B-cell
RT   lymphoma cell Line A-20 as a model for sporadic Burkitt's lymphoma.";
RL   J. Histochem. Cytochem. 65:669-677(2017).
//
RX   PubMed=31220119; DOI=10.1371/journal.pone.0218412;
RA   Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S.,
RA   Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H.,
RA   Li J.-L., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B.,
RA   Natoli M., Bauer B.A., Gollin S.M., Lewis D.W., Reid Y.A.;
RT   "Interlaboratory study to validate a STR profiling method for
RT   intraspecies identification of mouse cell lines.";
RL   PLoS ONE 14:E0218412-E0218412(2019).
//